Cinacalcet: An oral calcimimetic agent for the managementof hyperparathyroidism

Based on the available evidence,cinacalcet is effective and well tolerated in the treatment of secondary HPT and refractory parathyroid carcinoma. Its use in primary HPT appears promising. Further investigations are needed to determine if cinacalcet can prevent the long-term complications of HPT and reduce mortality.